The Merlin team had a very successful plenary in Rotterdam on 10 and 11 May. Updates were presented on each WP. MSC production and preparation for the upcoming trial were naturally a key focus at this stage of the project. Publications and plans for future work were also discussed. Many thanks to EMC for hosting and to all the partners for their input into a very productive and enjoyable meeting!
- RT @AutoCRAT2020: #MyFirstTweet! Greetings all! We are a @EU_H2020 research project! Please follow us if you are interested in #celltherapy… Time ago 3 Days via Twitter for iPhone
- RT @FP7Merlin: Up to 56 patients are being recruited to take part in the @FP7Merlin trial, which will investigate the safety and efficacy o… Time ago 13 Days via Twitter for iPhone
- RT @DrDeeds3: Orbsen are hiring a senior GMP production scientist in Birmingham! #celltherapy @Orbsen t.co/J1dmbLjLFv Time ago 67 Days via Twitter for iPhone
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.